Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
about
Systemic Sclerosis and Malignancy: A Review of Current DataScleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvementRecent advances in the genetics of systemic sclerosis: toward biological and clinical significanceHaematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.Review: cancer-induced autoimmunity in the rheumatic diseases.Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional studyExamination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature.Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.RNA Polymerase III Advances: Structural and tRNA Functional Views.Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.Molecular and cellular basis of scleroderma.Cytokines in the immunopathology of systemic sclerosis.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.Orofacial manifestations of systemic sclerosis.Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk.RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients with Breast Cancer.Biomarkers in connective tissue diseases.Autoimmunity and Gastric Cancer.Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.A 66-Year-Old Woman With Hemoptysis.The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblastsAtypical rapid onset Scleroderma Renal Crisis (SRC) complicated with diffuse alveolar hemorrhage and pleuro-pericardial effusions in a patient with recently diagnosed breast cancer and a positive anti-RNA polymerase III Ab.: A case report
P2860
Q26740318-00033721-3894-4580-BDF2-3398025DDAF7Q26995764-44C59164-4C00-4479-845B-6B11A3B52521Q28088499-D3C9D9FC-E695-465B-B708-FF71D4FCC49EQ33701364-0395DCEF-E95B-4D64-BEA8-24E3874313A0Q34666066-FB63E7B2-1A00-475F-8345-F41B243D78F7Q35092247-C44C1268-FC04-40DF-A099-DD4E4A812E77Q35454043-9F6F9F3B-244F-4EE0-96C6-E471C4BE52EEQ36236215-454853B5-3920-42AF-8628-B0007F36C807Q36276815-BE0A60E7-E717-45BB-9583-70F05E49C148Q36944786-A205DE8F-1DA4-45FA-895B-79B7051B6D42Q37100264-CBD09B5B-1F7A-47D1-927A-7B2507AD1147Q38230276-F981759F-6949-41AA-8790-C7D7E5331412Q38543692-91B8C918-D928-468F-93EE-BB5ADC3F8CCFQ38630663-F0571F8F-0CB7-41B5-AF69-69842C706BD9Q38952138-D9F4AD3E-A3B1-4868-A7E2-C020CF45B89EQ38962120-40EBD595-A02D-4DD5-83E6-500683CD95CEQ38979780-75A8DC7E-4CAF-43EE-BCA1-7B2F9380247FQ39432157-918CC388-2660-4EDF-941A-264950967A76Q40241820-2DD0A752-53A5-44B6-B12F-94BE8DC959ABQ40402537-17BD128E-9C3E-4DD8-8B68-A1786FF72E66Q40656308-DEE6A9CB-F24D-48C6-9E43-254B53DF41E6Q40803492-1521C383-ABC5-45C5-B566-187BCFC7C0E9Q41187671-73D6F862-80FD-403A-A275-AD2E5A565E77Q47177523-B97F25E0-C84B-4A72-93D1-54DA765940BDQ47314399-CFF87B06-1A4B-434F-8BD8-3D1F83A3BB98Q49652793-17DA5C6A-5C4A-4E1F-8AE8-81FED4C8687FQ50216162-1D730A78-10B2-42A4-A4A2-8A2AB6EE1F23Q52597638-90190583-CEA1-48D7-A26F-9F6704E9D96EQ54287978-EC777B25-7173-4002-AE3B-A5EDE933E281Q55070916-7EDCEAA4-E106-417E-A24A-093F4287E26DQ55334988-B6826474-5EAE-4831-8B4C-1050AE3E5E12Q58694714-C831E936-06CA-47A1-AE86-436A41C3B31EQ58769998-D2575269-279D-4889-8FBC-DBD683EF974A
P2860
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@en
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@nl
type
label
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@en
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@nl
prefLabel
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@en
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
@nl
P2093
P2860
P356
P1476
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
@en
P2093
Ami A Shah
Carmen Fonseca
Christopher P Denton
Martin Hellmich
Pia Moinzadeh
Voon H Ong
P2860
P2888
P356
10.1186/AR4486
P577
2014-02-14T00:00:00Z
P5875
P6179
1043305291